Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 235 | $31,547,064 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,270 | 12.3873 | 40,506 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 3,272 | 11.7468 | 38,436 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,423 | 10.8658 | 37,194 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 4,700 | 7.6168 | 35,799 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 4,000 | 8.8337 | 35,335 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 4,000 | 8.0904 | 32,362 | I |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 1,991 | 14.3626 | 28,596 | D |
03 Jun 2024 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 30 May 2024 | Sale | 3,000 | 8.775 | 26,325 | D |
02 Jun 2023 18:05 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 31 May 2023 | Sale | 3,000 | 8.6294 | 25,888 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 2,173 | 11.8005 | 25,642 | I |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 2,937 | 8.639 | 25,373 | D |
02 Oct 2023 18:19 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Sep 2023 | Sale | 3,000 | 7.7198 | 23,159 | D |
29 Apr 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Apr 2024 | Sale | 3,000 | 7.6735 | 23,020 | D |
03 Jul 2023 15:21 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Jun 2023 | Sale | 3,000 | 7.49 | 22,470 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 4,000 | 5.1411 | 20,564 | I |
17 Nov 2023 17:53 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 16 Nov 2023 | Sale | 3,000 | 6.7599 | 20,280 | D |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 4,000 | 4.9058 | 19,623 | I |
30 Oct 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Oct 2023 | Sale | 3,000 | 5.6283 | 16,885 | D |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Feb 2023 | Sale | 1,768 | 8.42 | 14,887 | D |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 962 | 14.0282 | 13,495 | I |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 1,067 | 10.9841 | 11,720 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6428 | 11,643 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6414 | 11,641 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 1,000 | 11.5621 | 11,562 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 12.4076 | 10,546 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0993 | 10,099 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0984 | 10,098 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2075 | 9,208 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2017 | 9,202 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 10.8206 | 9,198 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 1,000 | 8.8363 | 8,836 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 1,000 | 8.0867 | 8,087 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9086 | 7,909 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9059 | 7,906 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 550 | 14.0291 | 7,716 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3907 | 7,391 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3822 | 7,382 | I |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 500 | 14.048 | 7,024 | D |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 610 | 11.3361 | 6,915 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 561 | 11.8245 | 6,634 | I |
01 Mar 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Feb 2023 | Purchase | 815 | 7.97 | 6,496 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 500 | 11.6421 | 5,821 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 1,000 | 5.137 | 5,137 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 500 | 10.1104 | 5,055 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 1,000 | 4.9151 | 4,915 | I |
02 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Feb 2023 | Purchase | 600 | 7.97 | 4,782 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 500 | 9.2648 | 4,632 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 500 | 9.2082 | 4,604 | I |
21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 309 | 13.0432 | 4,030 | D |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 500 | 7.9041 | 3,952 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 500 | 7.3789 | 3,689 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 236 | 10.8698 | 2,565 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 14.0601 | 1,786 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 12.3559 | 1,569 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 63 | 13.7541 | 867 | I |
03 Oct 2022 19:32 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Sep 2022 | Sale | 64 | 11.53 | 738 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 63 | 9.4532 | 596 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 13 | 14.85 | 193 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)